How to Measure DELIVERed Benefits of Dapagliflozin in the Management of HFmrEF/HFpEF?

被引:0
|
作者
Tanaka, Atsushi [1 ]
Sawami, Kosuke [1 ]
Node, Koichi [1 ]
机构
[1] Saga Univ, Dept Cardiovasc Med, 5-1-1 Nabeshima, Saga 8498501, Japan
关键词
D O I
10.1016/j.jchf.2022.11.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:261 / 261
页数:1
相关论文
共 50 条
  • [31] QUALITY OF CARE ASSESSMENT FOR BREAST-CANCER - HOW TO MEASURE BENEFITS OF PREVENTION AND THERAPY IN ONCOLOGY
    LIBERATI, A
    FOSSATI, R
    TORRI, W
    BULLETIN DU CANCER, 1987, 74 (03) : 313 - 321
  • [32] How do you measure pleasure? A discussion about intrinsic costs and benefits in primate allogrooming
    Russell, Yvan I.
    Phelps, Steve
    BIOLOGY & PHILOSOPHY, 2013, 28 (06) : 1005 - 1020
  • [33] How do you measure pleasure? A discussion about intrinsic costs and benefits in primate allogrooming
    Yvan I. Russell
    Steve Phelps
    Biology & Philosophy, 2013, 28 : 1005 - 1020
  • [34] Integrating Benefits from Sustainability into the Competitive Assessment-How Can We Measure Them?
    Inderst, Roman
    Thomas, Stefan
    JOURNAL OF EUROPEAN COMPETITION LAW & PRACTICE, 2021, 12 (09) : 705 - 709
  • [35] Who is responsible for operating room management and how do we measure how well we do it?
    Marjamaa, R. A.
    Kirvela, O. A.
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2007, 51 (07) : 809 - 814
  • [36] How Green Management Influences Product Innovation in China: The Role of Institutional Benefits
    Chengli Shu
    Kevin Z. Zhou
    Yazhen Xiao
    Shanxing Gao
    Journal of Business Ethics, 2016, 133 : 471 - 485
  • [37] How to balance risks and benefits in the management of CKD patients with coronary artery disease
    Giancarlo Marenzi
    Nicola Cosentino
    Carlo Guastoni
    Journal of Nephrology, 2015, 28 : 403 - 413
  • [38] When and how much to neutralize interference? Balancing the benefits and cost of interference management
    Zhao Li
    Jun Li
    Jiamin Ding
    Ke Long
    Jia Liu
    Wireless Networks, 2020, 26 : 5393 - 5410
  • [39] How to balance risks and benefits in the management of CKD patients with coronary artery disease
    Marenzi, Giancarlo
    Cosentino, Nicola
    Guastoni, Carlo
    JOURNAL OF NEPHROLOGY, 2015, 28 (04) : 403 - 413
  • [40] When and how much to neutralize interference? Balancing the benefits and cost of interference management
    Li, Zhao
    Li, Jun
    Ding, Jiamin
    Long, Ke
    Liu, Jia
    WIRELESS NETWORKS, 2020, 26 (07) : 5393 - 5410